Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00836589 · ClinicalTrials.gov registry record
Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY)
A clinical trial of Patients Indicated for an ICD, sponsored by Biotronik.
- Completed
- Registry status
- 1,997
- Enrollment target
- 20
- Study locations
NCT00836589 is a study of Patients Indicated for an ICD that has completed, run by Biotronik. The registered enrollment target is 1,997 participants. The trial reports 20 study locations across 3 states.
The verdict
NCT00836589, a study of Patients Indicated for an ICD, has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- 1,997 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to confirm the long-term safety and reliability of the Linox Lead System as used with BIOTRONIK ICDs. The GALAXY registry will provide data to fully characterize ICD lead failures, from implant through 5 years, including those failures contributing to patients losing pacing or defibrillation therapy.
Conditions Studied
Interventions
- DEVICE ICD Therapy - ICD Lead Registry
Study Locations (20)
California
- - Burbank
- - Fairfield
- - Fountain Valley
- - Glendale
- - Hawthorne
- - Inglewood
- - Los Angeles
- - Mission Viejo
- - Northridge
- - Rancho Mirage
- - Santa Barbara
Arizona
- - Glendale
- - Mesa
- - Phoenix
- - Scottsdale
- - Tucson
Alabama
- - Albertville
- - Birmingham
- - Gadsden
- - Jasper
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,997 participants |
| Start Date | 2008-12 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00836589
The ClinicalTrials.gov registry entry for NCT00836589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,997 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patients Indicated for an ICD appearing as the primary indexed condition, and to 1 intervention - of which ICD Therapy - ICD Lead Registry is the first listed.
NCT00836589 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT00836589 about?
NCT00836589 is a clinical study titled "Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY)". The objective of this study is to confirm the long-term safety and reliability of the Linox Lead System as used with BIOTRONIK ICDs. The GALAXY registry will provide data to fully characterize ICD lead failures, from implant through 5 years, including those failures contributing to patients losing p...
What is the current status of trial NCT00836589?
This trial is currently completed. The enrollment target is 1,997 participants. The study started on 2008-12. Estimated completion is 2016-12.
What conditions does trial NCT00836589 study?
This clinical trial studies the following conditions: Patients Indicated for an ICD.
What interventions are being tested in trial NCT00836589?
The interventions under investigation include: ICD Therapy - ICD Lead Registry (DEVICE).
Who is sponsoring clinical trial NCT00836589?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00836589 being conducted?
This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.